{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:58:20Z","timestamp":1791644300880,"version":"4.3.4"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cca.2020.07.041","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T20:49:09Z","timestamp":1595450949000},"page":"310-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases"],"prefix":"10.1016","volume":"509","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2275-2871","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Bessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Albino-Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Reina-Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0005","doi-asserted-by":"crossref","DOI":"10.1111\/apha.12860","article-title":"Mind the gap: mechanisms regulating the endothelial barrier","volume":"222","author":"Radeva","year":"2018","journal-title":"Acta Physiol. (Oxford, England)"},{"key":"10.1016\/j.cca.2020.07.041_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/694312","article-title":"Modulation of endothelial glycocalyx structure under inflammatory conditions","volume":"2014","author":"Kolarova","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cca.2020.07.041_b0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-319-57613-8_4","article-title":"Endothelial Cells","volume":"1003","author":"Sturtzel","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aeh163","article-title":"Physiology of the endothelium","volume":"93","author":"Galley","year":"2004","journal-title":"Br. J. Anaesth."},{"issue":"12","key":"10.1016\/j.cca.2020.07.041_b0025","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/bph.13517","article-title":"Targeting vascular (endothelial) dysfunction","volume":"174","author":"Daiber","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.cca.2020.07.041_b0030","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7150\/ijbs.7502","article-title":"The vascular endothelium and human diseases","volume":"9","author":"Rajendran","year":"2013","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.cca.2020.07.041_b0035","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/bph.13517","article-title":"Targeting vascular (endothelial) dysfunction","volume":"174","author":"Daiber","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.cca.2020.07.041_b0040","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s00134-010-1893-6","article-title":"The endothelium: physiological functions and role in microcirculatory failure during severe sepsis","volume":"36","author":"Ait-Oufella","year":"2010","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cca.2020.07.041_b0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension","volume":"956","author":"Konukoglu","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cca.2020.07.041_b0050","article-title":"Endothelial function in cardiovascular precision medicine: a Position Paper on behalf of the European Society of Cardiology","author":"Alexander","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0055","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1172\/JCI66843","article-title":"Linking endothelial dysfunction with endothelial cell activation","volume":"123","author":"Liao","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199007053230105","article-title":"Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension","volume":"323","author":"Panza","year":"1990","journal-title":"New England J. Med."},{"issue":"13","key":"10.1016\/j.cca.2020.07.041_b0070","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/01.CIR.0000012543.55874.47","article-title":"Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study","volume":"105","author":"Gokce","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000426","article-title":"Peripheral endothelial function and cardiovascular events in high\u2010risk patients","volume":"2","author":"Matsuzawa","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0080","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.amjcard.2012.11.020","article-title":"Comparison of brachial artery wall thickness versus endothelial function to predict late cardiovascular events in patients undergoing elective coronary angiography","volume":"111","author":"Suessenbacher","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.cca.2020.07.041_b0085","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0003319720903586","article-title":"Novel biomarkers for evaluation of endothelial dysfunction","volume":"71","author":"Leite","year":"2020","journal-title":"Angiology"},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2217\/bmm.10.61","article-title":"Endothelial function as a functional expression of cardiovascular risk factors","volume":"4","author":"Reriani","year":"2010","journal-title":"Biomark. Med."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/hrt.2003.032847","article-title":"Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques","volume":"91","author":"Tousoulis","year":"2005","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.cca.2020.07.041_b0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","article-title":"The clinical implications of endothelial dysfunction","volume":"42","author":"Widlansky","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.cca.2020.07.041_b0110","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0115","first-page":"262","article-title":"Methods of endothelial function assessment: description and applications","volume":"30","author":"Storch","year":"2017","journal-title":"Int. J. Cardiovascular Sci."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0120","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1212\/NXI.0000000000000531","article-title":"HIV is associated with endothelial activation despite ART, in a sub-Saharan African setting","volume":"6","author":"Kamtchum-Tatuene","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.cca.2020.07.041_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9759735","article-title":"Markers and biomarkers of endothelium: when something is rotten in the state","volume":"2017","author":"Goncharov","year":"2017","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0130","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3390\/jcm9061995","article-title":"Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: potential diagnostic biomarkers and therapeutic targets","volume":"9","author":"Scioli","year":"2020","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0135","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1017\/S0007114516002804","article-title":"Oxidative stress and nitric oxide are increased in obese children and correlate with cardiometabolic risk and renal function","volume":"116","author":"Correia-Costa","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.cca.2020.07.041_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2018.10.007","article-title":"L-proline supplementation improves nitric oxide bioavailability and counteracts the blood pressure rise induced by angiotensin II in rats","volume":"82","author":"Leal","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.cca.2020.07.041_b0145","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00726-014-1825-9","article-title":"L-Arginine and its metabolites in kidney and cardiovascular disease","volume":"46","author":"Popolo","year":"2014","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","article-title":"The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease","volume":"6","author":"Sibal","year":"2010","journal-title":"Current Cardiol. Rev."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejim.2007.04.002","article-title":"Endothelins in health and disease","volume":"18","author":"Shah","year":"2007","journal-title":"Europ. J. Int. Med."},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0160","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/HYPERTENSIONAHA.108.117366","article-title":"Role of endothelin-1 in clinical hypertension: 20 years on","volume":"52","author":"Dhaun","year":"2008","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.cca.2020.07.041_b0165","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.3390\/ijms140918488","article-title":"Novel strategies for the prevention and treatment of biofilm related infections","volume":"14","author":"Chen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2020.07.041_b0170","series-title":"Endothelium and cardiovascular diseases: Vascular biology and clinical syndromes","author":"Da Luz","year":"2018"},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/ijms19020588","article-title":"New insights into the immune molecular regulation of the pathogenesis of acute Respiratory Distress Syndrome","volume":"19","author":"Yang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"34","key":"10.1016\/j.cca.2020.07.041_b0180","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1074\/jbc.271.34.20458","article-title":"ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines","volume":"271","author":"Lassalle","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"51","key":"10.1016\/j.cca.2020.07.041_b0185","doi-asserted-by":"crossref","first-page":"48341","DOI":"10.1074\/jbc.M108395200","article-title":"Endocan is a novel chondroitin sulfate\/dermatan sulfate proteoglycan that promotes hepatocyte growth factor\/scatter factor mitogenic activity","volume":"276","author":"Bechard","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000025758","article-title":"Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies","volume":"37","author":"Bechard","year":"2000","journal-title":"J. Vasc. Res."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0195","first-page":"25","article-title":"Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy","volume":"1765","author":"Sarrazin","year":"2006","journal-title":"BBA"},{"issue":"11","key":"10.1016\/j.cca.2020.07.041_b0200","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/glycob\/cwq100","article-title":"Characterization and binding activity of the chondroitin\/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan","volume":"20","author":"Sarrazin","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.cca.2020.07.041_b0205","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619852163","article-title":"Endothelial dysfunction is associated with mortality and severity of coagulopathy in patients with sepsis and disseminated intravascular coagulation","volume":"25","author":"Walborn","year":"2019","journal-title":"Clin. Appl. Thrombosis\/Hemostasis: Off. J. Int. Acad. Clin. Appl. Thrombosis\/Hemostasis"},{"key":"10.1016\/j.cca.2020.07.041_b0210","doi-asserted-by":"crossref","first-page":"2476845","DOI":"10.1155\/2019\/2476845","article-title":"Endocan, a risk factor for developing acute respiratory distress syndrome among severe pneumonia patients","volume":"2019","author":"Ying","year":"2019","journal-title":"Can. Respiratory J."},{"issue":"9","key":"10.1016\/j.cca.2020.07.041_b0215","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0003319713513492","article-title":"Endocan\u2013a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study","volume":"65","author":"Balta","year":"2014","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0220","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1076029616639701","article-title":"The relation between endocan levels and subclinic atherosclerosis","volume":"22","author":"Balta","year":"2016","journal-title":"Clin. Appl. Thrombosis\/Hemostasis: Off. J. Int. Acad. Clin. Appl. Thrombosis\/Hemostasis"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13613-017-0311-4","article-title":"Endocan as an early biomarker of severity in patients with acute respiratory distress syndrome","volume":"7","author":"Orbegozo","year":"2017","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.cca.2020.07.041_b0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cca.2018.05.007","article-title":"Concentration and value of endocan on outcome in adult patients after severe sepsis","volume":"483","author":"Hsiao","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"14","key":"10.1016\/j.cca.2020.07.041_b0235","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3109\/14767058.2014.964676","article-title":"Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes","volume":"28","author":"Adekola","year":"2015","journal-title":"J. Maternal-Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0240","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000447587","article-title":"Evaluation of cardiovascular risk factors, haematological and biochemical parameters, and serum endocan levels in patients with lichen planus","volume":"232","author":"Ozlu","year":"2016","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0245","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13054-018-2222-7","article-title":"Endocan, sepsis, pneumonia, and acute respiratory distress syndrome","volume":"22","author":"De Freitas Caires","year":"2018","journal-title":"Crit. Care"},{"key":"10.1016\/j.cca.2020.07.041_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/705027","article-title":"Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan","volume":"2013","author":"Delehedde","year":"2013","journal-title":"Int. J. Cell Biol."},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0255","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/10520295.2011.577754","article-title":"Expression and distribution of endocan in human tissues","volume":"87","author":"Zhang","year":"2012","journal-title":"Biotech Histochem."},{"key":"10.1016\/j.cca.2020.07.041_b0260","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.2147\/COPD.S118692","article-title":"Endocan and the respiratory system: a review","volume":"11","author":"Kechagia","year":"2016","journal-title":"Int. J. Chronic Obstruct. Pulmonary Disease"},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0265","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11060-014-1377-6","article-title":"Endocan, a new invasion and angiogenesis marker of pituitary adenomas","volume":"117","author":"Matano","year":"2014","journal-title":"J. Neurooncol."},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0270","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/NEN.0b013e3181a52a7f","article-title":"Endocan expression and localization in human glioblastomas","volume":"68","author":"Maurage","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"15","key":"10.1016\/j.cca.2020.07.041_b0275","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1158\/1078-0432.CCR-06-0185","article-title":"Endocan expression and relationship with survival in human non-small cell lung cancer","volume":"12","author":"Grigoriu","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0280","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2559.2009.03458.x","article-title":"Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma","volume":"56","author":"Leroy","year":"2010","journal-title":"Histopathology"},{"issue":"19","key":"10.1016\/j.cca.2020.07.041_b0285","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1182\/blood-2010-02-270819","article-title":"Identification and functional analysis of endothelial tip cell-enriched genes","volume":"116","author":"del Toro","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0290","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.krcp.2016.07.001","article-title":"Plasma endocan level and prognosis of immunoglobulin A nephropathy","volume":"35","author":"Lee","year":"2016","journal-title":"Kidney Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0295","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0004563216629169","article-title":"The determination of serum and urinary endocan concentrations in patients with bladder cancer","volume":"53","author":"Laloglu","year":"2016","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0300","doi-asserted-by":"crossref","first-page":"662","DOI":"10.18632\/oncotarget.23087","article-title":"Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma","volume":"9","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","article-title":"Serum endocan levels as a marker of disease activity in patients with Beh\u00e7et disease","volume":"70","author":"Balta","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.cca.2020.07.041_b0310","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.yexcr.2007.01.021","article-title":"Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer","volume":"313","author":"Rennel","year":"2007","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0315","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/path.4072","article-title":"Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFbeta2 in vascular abnormalization","volume":"228","author":"Dieterich","year":"2012","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0320","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3892\/or.2012.2012","article-title":"Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1alpha in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features","volume":"28","author":"Kim","year":"2012","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0325","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/jcp.27016","article-title":"ESM-1 promotes adhesion between monocytes and endothelial cells under intermittent hypoxia","volume":"234","author":"Sun","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0330","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1479164115583192","article-title":"Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction","volume":"12","author":"Nirala","year":"2015","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0335","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.24485","article-title":"Endocan elicits severe vascular inflammatory responses in vitro and in vivo","volume":"229","author":"Lee","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cca.2020.07.041_b0340","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2016.03.006","article-title":"Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass","volume":"83","author":"Madhivathanan","year":"2016","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0345","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/0003319715590558","article-title":"Effect of CPAP on new endothelial dysfunction marker, endocan, in people with obstructive sleep apnea","volume":"67","author":"Altintas","year":"2016","journal-title":"Angiology"},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0350","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/0008-5472.CAN-12-1855","article-title":"Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis","volume":"73","author":"Roudnicky","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0355","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/147323001003800213","article-title":"Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion","volume":"38","author":"Chen","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.cca.2020.07.041_b0360","unstructured":"P. Menon, O.N. Kocher, W.C. Aird, Abstract 15455: Endothelial Cell Specific Molecule-1 (ESM-1), a Novel Secreted Proteoglycan Stimulates Vascular Smooth Muscle Cell Proliferation and Migration, Circulation 124(suppl_21) (2011) A15455-A15455."},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0365","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-010-0277-9","article-title":"Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor","volume":"100","author":"Karthikeyan","year":"2011","journal-title":"Clin. Res. Cardiol."},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0370","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/01.CIR.91.6.1732","article-title":"Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway","volume":"91","author":"Panza","year":"1995","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cca.2020.07.041_b0375","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ. Res."},{"issue":"Suppl 1","key":"10.1016\/j.cca.2020.07.041_b0380","doi-asserted-by":"crossref","first-page":"i20","DOI":"10.1136\/heart.84.suppl_1.i20","article-title":"Endothelial dysfunction: the role and impact of the renin-angiotensin system","volume":"84","author":"L\u00fcscher","year":"2000","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0385","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/0971-5916.195022","article-title":"Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications","volume":"144","author":"Radenkovic","year":"2016","journal-title":"Indian J. Med. Res."},{"issue":"17","key":"10.1016\/j.cca.2020.07.041_b0390","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.102.17.2118","article-title":"Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation","volume":"102","author":"Piqueras","year":"2000","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cca.2020.07.041_b0395","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jacc.2004.07.027","article-title":"Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women","volume":"44","author":"Rossi","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2020.07.041_b0400","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ajh.2011.88","article-title":"Prehypertension is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation in sedentary adults","volume":"24","author":"Weil","year":"2011","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0405","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/01.CIR.94.6.1298","article-title":"Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients","volume":"94","author":"Taddei","year":"1996","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cca.2020.07.041_b0410","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/HJH.0000000000000965","article-title":"Endothelial dysfunction in human essential hypertension","volume":"34","author":"Mordi","year":"2016","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0415","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.CIR.104.2.191","article-title":"Prognostic significance of endothelial dysfunction in hypertensive patients","volume":"104","author":"Perticone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2020.07.041_b0420","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/281240","article-title":"Vascular inflammation and endothelial dysfunction in experimental hypertension","volume":"2011","author":"Savoia","year":"2011","journal-title":"Int. J. Hypertension"},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0425","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0003319717736158","article-title":"Endocan concentration in patients with primary hypertension","volume":"69","author":"Musialowska","year":"2018","journal-title":"Angiology"},{"key":"10.1016\/j.cca.2020.07.041_b0430","series-title":"Immunoassay performance measures","first-page":"11","author":"Davies","year":"2013"},{"issue":"3\u20134","key":"10.1016\/j.cca.2020.07.041_b0435","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/prca.201400130","article-title":"ELISA in the multiplex era: potentials and pitfalls","volume":"9","author":"Tighe","year":"2015","journal-title":"Proteomics Clin. Appl."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0440","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/acs.chemrev.8b00257","article-title":"Highly sensitive and multiplexed protein measurements","volume":"119","author":"Cohen","year":"2018","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.cca.2020.07.041_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021230","article-title":"Differences between human plasma and serum metabolite profiles","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0450","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4070\/kcj.2016.46.6.827","article-title":"Endocan and non-dipping circadian pattern in newly diagnosed essential hypertension","volume":"46","author":"\u00c7imen","year":"2016","journal-title":"Korean Circ. J."},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120914","article-title":"Sympathoadrenal activation and endothelial damage are inter correlated and predict increased mortality in patients resuscitated after out-of-hospital cardiac arrest. a post Hoc sub-study of patients from the TTM-trial","volume":"10","author":"Johansson","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2020.07.041_b0460","doi-asserted-by":"crossref","unstructured":"S.F. Oktar, I. Guney, S.A. Eren, L. Oktar, K. Kosar, Z. Buyukterzi, E. Alkan, Z. Biyik, S.S. Erdem, Serum endocan levels, carotid intima-media thickness and microalbuminuria in patients with newly diagnosed hypertension, Clin. Exp. Hypertension (New York, N.Y.: 1993) (2019) 1-8.","DOI":"10.1080\/10641963.2019.1652632"},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0465","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/gtmb.2014.0274","article-title":"Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension","volume":"19","author":"Wang","year":"2015","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"49","key":"10.1016\/j.cca.2020.07.041_b0470","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013407","article-title":"The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis","volume":"97","author":"Zhao","year":"2018","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.cca.2020.07.041_b0475","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/JIM.0000000000000219","article-title":"Elevated human endothelial cell-specific molecule-1 level and its association with coronary artery disease in patients with hypertension","volume":"63","author":"Xiong","year":"2015","journal-title":"J. Invest. Med."},{"issue":"7","key":"10.1016\/j.cca.2020.07.041_b0480","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/0003319718823625","article-title":"The relationship between serum endocan level and aortic elastic properties in patients with newly diagnosed essential hypertension","volume":"70","author":"Celik","year":"2019","journal-title":"Angiology"},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0485","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ancard.2018.04.023","article-title":"Biochemical markers of hypertension, prehypertension","volume":"67","author":"Turgunova","year":"2018","journal-title":"Ann. Cardiol. Angeiol."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0490","first-page":"76","article-title":"Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?","volume":"21","author":"Agac","year":"2019","journal-title":"Anatolian J. Cardiol."},{"key":"10.1016\/j.cca.2020.07.041_b0495","doi-asserted-by":"crossref","unstructured":"Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.F.G., Coats A.J.S., Falk V., Gonz\u00e1lez-Juanatey J. R., Harjola V., Jankowska E. A., Jessup M., Linde C., Nihoyannopoulos P., Parissis J.T., Pieske B., Riley J.P., Rosano G.M.C., Ruilope L.M., Ruschitzka F., Rutten F.H., van der Meer P., Authors\/Task Force Members, Document Reviewers, et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur. J. Heart Fail.18 (8) (2016) 891\u2013975.","DOI":"10.1002\/ejhf.592"},{"key":"10.1016\/j.cca.2020.07.041_b0500","series-title":"Oxidative Stress in Heart Diseases","first-page":"509","article-title":"Role of oxidative stress in the pathophysiology of arterial hypertension and heart failure","author":"Sousa","year":"2019"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0505","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrcardio.2015.134","article-title":"Pathophysiology and clinical evaluation of acute heart failure","volume":"13","author":"Mentz","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0510","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.CIR.0000153349.77489.CF","article-title":"Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure","volume":"111","author":"Katz","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0515","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.109.864801","article-title":"Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study","volume":"120","author":"Yeboah","year":"2009","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.cca.2020.07.041_b0520","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/CIRCULATIONAHA.110.984047","article-title":"Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease","volume":"123","author":"Lind","year":"2011","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.cca.2020.07.041_b0525","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.3390\/ijms20133198","article-title":"Endothelial dysfunction in chronic heart failure: assessment, findings, significance, and potential therapeutic targets","volume":"20","author":"Alem","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0530","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/0735-1097(92)90271-N","article-title":"Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure","volume":"19","author":"Katz","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0535","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/01.CIR.84.4.1589","article-title":"Endothelium-dependent vasodilation is attenuated in patients with heart failure","volume":"84","author":"Kubo","year":"1991","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0540","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0545","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/HYPERTENSIONAHA.112.193318","article-title":"Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond","volume":"60","author":"Witman","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0550","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1161\/01.RES.0000012569.55432.02","article-title":"Effects of angiotensin II infusion on the expression and function of NAD (P) H oxidase and components of nitric oxide\/cGMP signaling","volume":"90","author":"Mollnau","year":"2002","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.cca.2020.07.041_b0555","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/01.CIR.0000041431.57222.AF","article-title":"Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase","volume":"106","author":"Landmesser","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cca.2020.07.041_b0560","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/01.CIR.0000124450.07016.1D","article-title":"Red blood cell nitric oxide as an endocrine vasoregulator: a potential role in congestive heart failure","volume":"109","author":"Datta","year":"2004","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.cca.2020.07.041_b0565","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMe048269","article-title":"Nitroso-redox balance in the cardiovascular system","volume":"351","author":"Hare","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.07.041_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2012.12.016","article-title":"Nitroso-redox imbalance affects cardiac structure and function","author":"Karantalis","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.cca.2020.07.041_b0575","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","article-title":"Endothelial dysfunction, arterial stiffness, and heart failure","volume":"60","author":"Marti","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0580","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cells9010242","article-title":"Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding","volume":"9","author":"Simmonds","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0585","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0590","first-page":"312","article-title":"Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction","volume":"4","author":"Franssen","year":"2016","journal-title":"JACC: Heart Failure"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0595","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10741-019-09881-3","article-title":"Role of endothelial dysfunction in heart failure","volume":"25","author":"Zuchi","year":"2020","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mayocpiqo.2018.12.006","article-title":"Rethinking endothelial dysfunction as a crucial target in fighting heart failure","volume":"3","author":"Premer","year":"2019","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"issue":"18","key":"10.1016\/j.cca.2020.07.041_b0605","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2012.07.036","article-title":"Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction","volume":"60","author":"Akiyama","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0610","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejheart.2007.12.007","article-title":"Acute heart failure as \u201cacute endothelitis\u201d\u2013Interaction of fluid overload and endothelial dysfunction","volume":"10","author":"Colombo","year":"2008","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0615","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi001","article-title":"Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death","volume":"26","author":"Fischer","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2020.07.041_b0620","doi-asserted-by":"crossref","first-page":"9134096","DOI":"10.1155\/2019\/9134096","article-title":"Endocan is an independent predictor of heart failure-related mortality and hospitalizations in patients with chronic stable heart failure","volume":"2019","author":"Kosir","year":"2019","journal-title":"Dis. Markers"},{"issue":"Suppl 1","key":"10.1016\/j.cca.2020.07.041_b0625","first-page":"114","article-title":"Endocan and resolvin-D1 association with ventricular dysfunction, lactic acidosis and prognostic scores in human acute heart failure","volume":"21","author":"Reina Couto","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"12","key":"10.1016\/j.cca.2020.07.041_b0630","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2020.07.041_b0635","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/asheducation-2005.1.436","article-title":"Pathogenesis of atherosclerosis","author":"Crowther","year":"2005","journal-title":"Hematology Am. Soc. Hematol. Educ. Program."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0640","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/10641960903443533","article-title":"Correlation between the levels of circulating adhesion molecules and atherosclerosis in hypertensive type-2 diabetic patients","volume":"32","author":"Rubio-Guerra","year":"2010","journal-title":"Clin. Exp. Hypertens."},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0645","first-page":"911","article-title":"Insulin administration in the mild hyperglycaemia changes expression of proinflammatory adhesion molecules on human aortic endothelial cells","volume":"34","author":"Bacun","year":"2010","journal-title":"Coll. Antropol."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0650","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/01.ATV.18.5.842","article-title":"Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse","volume":"18","author":"Nakashima","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2020.07.041_b0655","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8563845","article-title":"Targeting early atherosclerosis: A focus on oxidative stress and inflammation","author":"Marchio","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0660","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011171","article-title":"Degradation of glycocalyx and multiple manifestations of endothelial dysfunction coincide in the early phase of endothelial dysfunction before atherosclerotic plaque development in apolipoprotein E\/low-density lipoprotein receptor-deficient mice","volume":"8","author":"Bar","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0665","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/01.CIR.95.2.324","article-title":"Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease","volume":"95","author":"Andrews","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0670","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jacc.2008.08.074","article-title":"Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease","volume":"53","author":"Kitta","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0675","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.81.2.491","article-title":"Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease","volume":"81","author":"Vita","year":"1990","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cca.2020.07.041_b0680","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0003319714548870","article-title":"Serum endocan level and the severity of coronary artery disease: a pilot study","volume":"66","author":"Kose","year":"2015","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0685","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0003319716646932","article-title":"Admission endocan level may be a useful predictor for in-hospital mortality and coronary severity index in patients with ST-segment elevation myocardial infarction","volume":"68","author":"Kundi","year":"2017","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0690","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0003319716634581","article-title":"Analysis of serum endothelial cell-specific molecule 1 (endocan) level in type 2 diabetes mellitus with acute ST-segment elevation myocardial infarction and its correlation: a pilot study","volume":"68","author":"Qiu","year":"2017","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0695","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12931-019-1143-6","article-title":"Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea","volume":"20","author":"Sun","year":"2019","journal-title":"Respir. Res."},{"issue":"9","key":"10.1016\/j.cca.2020.07.041_b0700","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0003319715621996","article-title":"Relationship of endothelial cell-specific molecule 1 level in stress hyperglycemia patients with acute ST-segment elevation myocardial infarction: a pilot study","volume":"67","author":"Qiu","year":"2016","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0705","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11239-016-1424-6","article-title":"Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion","volume":"43","author":"Emet","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0710","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0003319717703835","article-title":"Endocan levels and coronary collateral circulation in stable angina pectoris: a pilot study","volume":"69","author":"Gok","year":"2018","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0715","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"JACC. Cardiovasc. Imaging"},{"issue":"9","key":"10.1016\/j.cca.2020.07.041_b0720","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/0003319715625827","article-title":"Human endothelial cell-specific molecule-1 (endocan) and coronary artery disease and microvascular angina","volume":"67","author":"Cimen","year":"2016","journal-title":"Angiology"},{"issue":"7","key":"10.1016\/j.cca.2020.07.041_b0725","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00392-013-0555-4","article-title":"Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application","volume":"102","author":"Sinning","year":"2013","journal-title":"Clin. Res. Cardiol."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0730","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0003319716651349","article-title":"Serum endothelial cell-specific molecule 1 (Endocan) levels in patients with acute myocardial infarction and its clinical significance","volume":"68","author":"Qiu","year":"2017","journal-title":"Angiology"},{"issue":"10","key":"10.1016\/j.cca.2020.07.041_b0735","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/0003319718815241","article-title":"Predictive value of endocan based on TIMI risk score on major adverse cardiovascular events after acute coronary syndrome","volume":"70","author":"Ziaee","year":"2019","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0740","first-page":"111","article-title":"Serum endocan levels predict drug-eluting stent restenosis in patients with stable angina pectoris","volume":"36","author":"K\u00fcp","year":"2020","journal-title":"Acta Cardiol. Sinica"},{"key":"10.1016\/j.cca.2020.07.041_b0745","article-title":"The biomarkers for acute myocardial infarction and heart failure","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res. Int."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0750","first-page":"321","article-title":"Clinical value of serum endocan and procalcitonin in early diagnosis and prognosis evaluation of sepsis","volume":"29","author":"Zhao","year":"2017","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0755","first-page":"37","article-title":"The coronary slow flow phenomenon: characteristics, mechanisms and implications","volume":"1","author":"Wang","year":"2011","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0760","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0765","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/1076029615618024","article-title":"The relationship between serum endocan levels with the presence of slow coronary flow: a cross-sectional study","volume":"23","author":"Kundi","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0770","first-page":"251","article-title":"[Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon]","volume":"47","author":"Sigirci","year":"2019","journal-title":"Turk. Kardiyol. Dern. Ars."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0775","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/00365513.2016.1177853","article-title":"Elevated endocan concentration is associated with coronary slow flow","volume":"76","author":"Ye","year":"2016","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0780","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.amjms.2017.02.004","article-title":"The association between endocan levels and subclinical atherosclerosis in patients with type 2 diabetes mellitus","volume":"353","author":"Lv","year":"2017","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.cca.2020.07.041_b0785","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.2147\/COPD.S182731","article-title":"Serum endocan levels in patients with stable COPD","volume":"13","author":"Pihtili","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"8","key":"10.1016\/j.cca.2020.07.041_b0790","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0003319715616240","article-title":"Endocan levels and subclinical atherosclerosis in patients with systemic lupus erythematosus","volume":"67","author":"Icli","year":"2016","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0795","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/bjd.12525","article-title":"Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease","volume":"169","author":"Balta","year":"2013","journal-title":"Brit. J. Dermatol."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0800","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0300-8932(10)70014-2","article-title":"Carotid intima-media thickness in subjects with no cardiovascular risk factors","volume":"63","author":"Jarauta","year":"2010","journal-title":"Rev. Esp. Cardiol."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0805","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/HCO.0000000000000174","article-title":"Erectile dysfunction and coronary heart disease","volume":"30","author":"Katsiki","year":"2015","journal-title":"Curr. Opin. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2020.07.041_b0810","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s11255-018-1946-2","article-title":"Is the plasma endocan level a reliable predictor for the severity of erectile dysfunction?","volume":"50","author":"Onuk","year":"2018","journal-title":"Int. Urol. Nephrol."},{"issue":"10","key":"10.1016\/j.cca.2020.07.041_b0815","doi-asserted-by":"crossref","DOI":"10.1111\/and.13113","article-title":"Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients","volume":"50","author":"Elkamshoushi","year":"2018","journal-title":"Andrologia"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0820","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2015.09.030","article-title":"Endocan: a novel inflammatory indicator in cardiovascular disease?","volume":"243","author":"Balta","year":"2015","journal-title":"Atherosclerosis"},{"issue":"13","key":"10.1016\/j.cca.2020.07.041_b0825","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"New England J. Med."},{"issue":"19\u201320","key":"10.1016\/j.cca.2020.07.041_b0830","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cca.2010.06.019","article-title":"Mechanism of endothelial dysfunction in chronic kidney disease","volume":"411","author":"Malyszko","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0835","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2020.07.041_b0840","doi-asserted-by":"crossref","unstructured":"V. Witko-Sarsat, M. Friedlander, T. Nguyen Khoa, C. Capeillere-Blandin, A.T. Nguyen, S. Canteloup, J.M. Dayer, P. Jungers, T. Drueke, B. Descamps-Latscha, Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure, J. Immunol. (Baltimore, Md.: 1950) 161(5) (1998) 2524-32.","DOI":"10.4049\/jimmunol.161.5.2524"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0845","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.cca.2020.07.041_b0850","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/ndt\/15.10.1624","article-title":"Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease","volume":"15","author":"Stenvinkel","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0855","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/ki.2014.227","article-title":"Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease","volume":"86","author":"Yilmaz","year":"2014","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0860","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.clinbiochem.2015.01.006","article-title":"Endocan\u2013the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease","volume":"48","author":"Pawlak","year":"2015","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0865","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1076029617729216","article-title":"Biomarkers of endothelial, renal, and platelet dysfunction in stage 5 chronic kidney disease hemodialysis patients with heart failure","volume":"24","author":"McMillan","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0870","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/1744-9987.12654","article-title":"Serum endocan levels are associated with paraoxonase 1 concentration in patients with chronic kidney disease and dialysis","volume":"22","author":"Samouilidou","year":"2018","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.cca.2020.07.041_b0875","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.12659\/MSM.900693","article-title":"Serum endocan as a predictive marker for decreased urine volume in peritoneal dialysis patients","volume":"23","author":"Oka","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0880","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5114\/aoms.2018.79488","article-title":"Evaluation of endocan and endoglin levels in chronic kidney disease due to diabetes mellitus","volume":"15","author":"Ekiz-Bilir","year":"2019","journal-title":"Arch. Med. Sci."},{"issue":"4","key":"10.1016\/j.cca.2020.07.041_b0885","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000488115","article-title":"Levels of endocan, angiopoietin-2, and hypoxia-inducible factor-1a in patients with autosomal dominant polycystic kidney disease and different levels of renal function","volume":"47","author":"Raptis","year":"2018","journal-title":"Am. J. Nephrol."},{"issue":"6","key":"10.1016\/j.cca.2020.07.041_b0890","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","article-title":"Chronic kidney disease as cause of cardiovascular morbidity and mortality","volume":"20","author":"Vanholder","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2020.07.041_b0895","doi-asserted-by":"crossref","unstructured":"Shulman N.B., Ford C.E., Hall W.D., Blaufox M.D., Simon D., Langford H. G., Schneider K.A. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(5 Suppl) (1989) I80-93.","DOI":"10.1161\/01.HYP.13.5_Suppl.I80"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0900","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0905","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41598-018-37975-9","article-title":"Endocan as a marker of microvascular inflammation in kidney transplant recipients","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2020.07.041_b0910","doi-asserted-by":"crossref","first-page":"2180765","DOI":"10.1155\/2016\/2180765","article-title":"Serum Endocan levels associated with hypertension and loss of renal function in pediatric patients after two years from renal transplant","volume":"2016","author":"Souza","year":"2016","journal-title":"Int. J. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0915","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1046\/j.1523-1755.2003.00909.x","article-title":"ICAM-1 expression and leukocyte accumulation in inner stripe of outer medulla in early phase of ischemic compared to HgCl2-induced ARF","volume":"63","author":"De Greef","year":"2003","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0920","first-page":"124","article-title":"Increase of endocan, a new marker for inflammation and endothelial dysfunction, in acute kidney injury","volume":"6","author":"Gunay","year":"2019","journal-title":"North. Clin. Istanbul"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0925","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13054-019-2349-1","article-title":"Impact of acute renal failure on plasmatic levels of cleaved endocan","volume":"23","author":"Gaudet","year":"2019","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0930","doi-asserted-by":"crossref","first-page":"A264","DOI":"10.1186\/2197-425X-3-S1-A264","article-title":"Elevated endocan levels are associated with development of renal failure in ARDS patients","volume":"3","author":"Rahmania","year":"2015","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.cca.2020.07.041_b0935","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","article-title":"The clinical implications of endothelial dysfunction","volume":"42","author":"Widlansky","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0940","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/08037051.2014.972816","article-title":"Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan","volume":"24","author":"Celik","year":"2015","journal-title":"Blood Press."},{"issue":"2\u20133","key":"10.1016\/j.cca.2020.07.041_b0945","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000350064","article-title":"The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapy","volume":"37","author":"Tadzic","year":"2013","journal-title":"Kidney Blood Pressure Res."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b0950","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.repc.2015.09.006","article-title":"Statins and oxidative stress in chronic heart failure","volume":"35","author":"Costa","year":"2016","journal-title":"Rev. Port. Cardiol."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0955","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/1741826711398430","article-title":"Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Reriani","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0960","first-page":"240","article-title":"Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction","volume":"22","author":"Tun\u00e7ez","year":"2019","journal-title":"Anatolian J. Cardiol."},{"key":"10.1016\/j.cca.2020.07.041_b0965","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijbiomac.2019.09.235","article-title":"In-silico and in-vitro analysis of endocan interaction with statins","volume":"146","author":"Kumar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b0970","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tracli.2018.03.006","article-title":"Platelet and TRALI: from blood component to organism","volume":"25","author":"Tariket","year":"2018","journal-title":"Transfus. Clin. Biol."},{"issue":"11","key":"10.1016\/j.cca.2020.07.041_b0975","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0980","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"issue":"25","key":"10.1016\/j.cca.2020.07.041_b0985","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b0990","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/ijms21051576","article-title":"Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease","volume":"21","author":"Aquila","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2020.07.041_b0995","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3892\/etm.2016.3987","article-title":"Effect of ticagrelor on the serum level of hs-CRP, ESM-1 and short-term prognosis of patients with acute STEMI","volume":"13","author":"Wei","year":"2017","journal-title":"Exp. Therap. Med."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b1000","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000491768","volume":"48","author":"Gao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b1005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5114\/aoms.2019.87541","article-title":"Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA1c) in patients with prediabetes and type 2 diabetes","volume":"16","author":"Klisic","year":"2020","journal-title":"Arch. Med. Sci."},{"issue":"8","key":"10.1016\/j.cca.2020.07.041_b1010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182932","article-title":"Identification of novel biomarkers to monitor \u03b2-cell function and enable early detection of type 2 diabetes risk","volume":"12","author":"Belongie","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.cca.2020.07.041_b1015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/0003319715585664","article-title":"Effect of glycemic regulation on endocan levels in patients with diabetes: a preliminary study","volume":"67","author":"Arman","year":"2016","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b1020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.arcmed.2019.08.012","article-title":"Metformin effect on endocan biogenesis in human endothelial cells under diabetic condition","volume":"50","author":"Zolali","year":"2019","journal-title":"Arch. Med. Res."},{"issue":"7","key":"10.1016\/j.cca.2020.07.041_b1025","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.109.914721","article-title":"Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race\/ethnicity","volume":"122","author":"Shiroma","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_b1030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/heartjnl-2014-306437","article-title":"Comparison of three current sets of electrocardiographic interpretation criteria for use in screening athletes","volume":"101","author":"Riding","year":"2015","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.cca.2020.07.041_b1035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12872-016-0452-7","article-title":"Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study","volume":"17","author":"Sponder","year":"2017","journal-title":"BMC Cardiovasc. Disord."},{"issue":"24","key":"10.1016\/j.cca.2020.07.041_b1040","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1182\/blood-2009-07-230284","article-title":"Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching","volume":"115","author":"Strasser","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cca.2020.07.041_bib1043","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4103\/njcp.njcp_616_18","article-title":"The relationship between the atherosclerotic cardiovascular disease risk score used in the prediction of cardiovascular disease risk and endocan","volume":"22","author":"Cakirca","year":"2019","journal-title":"Niger. J. Clin. Pract."},{"issue":"11","key":"10.1016\/j.cca.2020.07.041_bib1044","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s11255-018-1993-8","article-title":"Serum endocan and circadian heart rate variability in non-dialysis stage 5 chronic kidney disease patients","volume":"50","author":"Bao","year":"2018","journal-title":"Int. Urol. Nephrol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812030365X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812030365X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:57:43Z","timestamp":1757861863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989812030365X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":210,"alternative-id":["S000989812030365X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.07.041","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}